These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2198027)

  • 1. Comparison of the in vitro activities of quassinoids with activity against Plasmodium falciparum, anisomycin and some other inhibitors of eukaryotic protein synthesis.
    Ekong RM; Kirby GC; Patel G; Phillipson JD; Warhurst DC
    Biochem Pharmacol; 1990 Jul; 40(2):297-301. PubMed ID: 2198027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies on the mode of action of quassinoids with activity against chloroquine-resistant Plasmodium falciparum.
    Kirby GC; O'Neill MJ; Phillipson JD; Warhurst DC
    Biochem Pharmacol; 1989 Dec; 38(24):4367-74. PubMed ID: 2690830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulatory effects of protein synthesis inhibitors on the spreading rate of 3T3 cells.
    Verger C; Petrovic M; Imbenotte J
    Cell Biol Int Rep; 1989 Mar; 13(3):231-5. PubMed ID: 2706685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anisomycin, acetoxycycloheximide, cycloheximide, and puromycin as inhibitors of rat brain acetylcholinesterase in vitro.
    Moss DE; Fahrney D
    J Neurochem; 1976 Jun; 26(6):1155-7. PubMed ID: 932721
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on memory: inhibitors of protein synthesis also inhibit catecholamine synthesis.
    Flexner LB; Goodman RH
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4660-3. PubMed ID: 1060144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel pyrrolidonoalkaneamine (WR268954) that modulates chloroquine resistance of Plasmodium falciparum in vitro.
    De D; Bhaduri AP; Milhous WK
    Am J Trop Med Hyg; 1993 Jul; 49(1):113-20. PubMed ID: 8352383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anisomycin and cycloheximide, like growth factors, stimulate rapidly ATP turnover in 3T3 cells.
    Talha S; Harel L
    Cell Biol Int Rep; 1986 Apr; 10(4):249-55. PubMed ID: 3518953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential use of methotrexate in the treatment of falciparum malaria: in vitro assays against sensitive and multidrug-resistant falciparum strains.
    Dar O; Khan MS; Adagu I
    Jpn J Infect Dis; 2008 May; 61(3):210-1. PubMed ID: 18503171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chloroquine-resistant malaria with esters of cephalotaxine: homoharringtonine.
    Whaun JM; Brown ND
    Ann Trop Med Parasitol; 1990 Jun; 84(3):229-37. PubMed ID: 2222025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of acetylcholinesterase by anisomycin.
    Zech R; Domagk GF
    Life Sci; 1976 Jul; 19(2):157-61. PubMed ID: 957862
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein synthesis requirement of the Aplysia circadian clock. Tested by active and inactive derivatives of the inhibitor anisomycin.
    Jacklet JW
    J Exp Biol; 1980 Apr; 85():33-42. PubMed ID: 7373209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
    Nakornchai S; Konthiang P
    Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antimalarial activity of quassinoids from Eurycoma longifolia against Malaysian chloroquine-resistant Plasmodium falciparum isolates.
    Ang HH; Chan KL; Mak JW
    Planta Med; 1995 Apr; 61(2):177-8. PubMed ID: 7753926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of chloroquine resistance in Plasmodium falciparum by CDR 87/209 and analogues.
    Walter RD; Seth M; Bhaduri AP
    Trop Med Parasitol; 1993 Mar; 44(1):5-8. PubMed ID: 8516635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial activity of quassinoids against chloroquine-resistant Plasmodium falciparum in vitro.
    Trager W; Polonsky J
    Am J Trop Med Hyg; 1981 May; 30(3):531-7. PubMed ID: 7020445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of inhibition of rabbit reticulocyte peptidyltransferase by anisomycin and sparsomycin.
    Ioannou M; Coutsogeorgopoulos C; Synetos D
    Mol Pharmacol; 1998 Jun; 53(6):1089-96. PubMed ID: 9614213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
    Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.
    Kreidenweiss A; Kremsner PG; Mordmüller B
    Malar J; 2008 Sep; 7():187. PubMed ID: 18816382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium falciparum: effects of phaeanthine, a naturally-occurring bisbenzylisoquinoline alkaloid, on chloroquine-resistant and -sensitive parasites in vitro, and its influence on chloroquine activity.
    Ekong R; Partridge SJ; Anderson MM; Kirby GC; Warhurst DC; Russell PF; Phillipson JD
    Ann Trop Med Parasitol; 1991 Apr; 85(2):205-13. PubMed ID: 1796863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.